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Detection of NDM-1-producing Enterobacteriaceae in Romania: report of the SENTRY Antimicrobial Surveillance Program
Gram-negative organisms producing NDM metallo-b-lactamases (MbLs) were detected in India as early as 2006 (Castanheira et al., 2011) and the Indian subcontinent has been considered the primary source of these MbL-producing organisms (Poirel et al., 2011) . The Balkan region that includes South-East European countries, such as Albania, Bulgaria, Greece and portions of Croatia, Italy, Macedonia, Romania and Serbia among other nations, has also been considered as a possible secondary source of NDMproducing isolates (Jovcic et al., 2011; Poirel et al., 2011) . Although reports have demonstrated the presence of NDMencoding genes in a few isolates from some of these countries or from patients that originated from the Balkan region (Poirel et al., 2011) , there are scarce data on the prevalence of these organisms from Romania. . These isolates were recovered in Bucharest (one NDM-1-producing E. cloacae and the OXA-48-producing K. pneumoniae) and Cluj-Napoca (one NDM-1-producing E. cloacae). All patients were male and the isolates were considered the cause of the reported clinical infection (urinary, lower respiratory or bloodstream; Table 1 ).
The carbapenemase-producing organisms were resistant to several antimicrobial agents tested (Table 1 ). The NDM-1 producing E. cloacae from Cluj-Napoca displayed aztreonam MIC results of a susceptible level (0.5 mg l 21 ), and the OXA-48-producer was susceptible when tested against aminoglycosides, tetracycline and colistin. Tigecycline was the only agent with coverage for all three isolates using USA-FDA breakpoints.
PFGE performed using SpeI and standard conditions demonstrated that the two NDM-1-producing E. cloacae were genetically unrelated. Partial S1 nuclease digest of total cellular DNA followed by hybridization with a bla NDM-1 specific probe (Castanheira et al., 2011) revealed that NDM-1 was located in a 97 kb plasmid in both strains, and these plasmids belonged to one incompatibility group, HI2 (Carattoli et al., 2005) . Additionally, DNA amplification followed by sequencing showed that ISAba125 was located immediately upstream of bla NDM-1 in both strains.
The NDM-1 producing isolate from Bucharest also harboured qnrA and rmtC, and the isolate from Cluj-Napoca carried bla OXA-1/30 , qnrB and rmtC. Qnr and 16S rRNA methylase proteins were likely to encode or contribute to elevated MIC values for fluoroquinolone and aminoglycoside in both isolates. The OXA-48-producing isolates harboured only genes encoding extended-spectrum blactamases (CTX-M-15 and DHA-1).
More evidence is needed to corroborate the hypotheses that the Balkan region is a source of NDM-producing isolates; however, this report confirms the presence of isolates producing this MbL in another country that is geographically associated with the Balkans. IMP and VIM types have been described from Romania (Mereuţȃ et al., 2007) , and in this study we describe isolates carrying the genes encoding NDM-1 and OXA-48. Furthermore, plasmids from both NDM-1-producing strains, collected in hospitals located in different Romanian cities, had the same size and incompatibility factor, suggesting that this genetic structure could be disseminated in this region or country. These findings highlight a possible endemic carbapenem-resistant enteric population problem in Romania, and focused infection control practices and surveillance of emergent strains seem warranted in this country.
